RxDoctor Payments Data

Andrew Hesseltine, MD

Pain Medicine · Colton, CANPI 1467438036

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (57.2%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 60 manufacturers reported payments, led by Nevro Corp. at 43.1% of the total. Among pain medicine clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$31,510in general payments, 2019–2025

Across 752 payments — averaging $41.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Nevro Corp.$14K
  • Medtronic$5K
  • Boston Scientific$3K
  • Abbott$1K
  • AbbVie$1K
  • Electronic Waveform Lab, Inc.$577
  • plus $7K from 54 others
$16,920in research payments, 2019–2025

Across 3 payments — averaging $5640.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$10K
  • GRT US Holding, Inc.$7K

What the payments were for

  • Consulting fees$5,52518%
  • Speaking & faculty fees$6,90022%
  • Travel & lodging$1,0403%
  • Food & beverage$18,02757%
  • Education$190%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Nevro Corp.120$13,582
Medtronic(2 entities)74$5,202
Boston Scientific69$2,761
Abbott27$1,098
AbbVie(2 entities)64$1,006
Electronic Waveform Lab, Inc.37$577
Foundation Fusion Solutions, LLC5$479
Painteq LLC16$439
Pfizer39$403
Globus Medical14$390
Saluda Medical Americas, Inc.8$360
Biotronik NRO, Inc.8$307
Supernus Pharmaceuticals, Inc.27$304
Curonix LLC4$304
Amgen(2 entities)18$271
Merz Pharmaceuticals, LLC7$267
Lilly USA, LLC13$250
Biodelivery Sciences International, Inc.16$219
Zyla Life Sciences, Inc.19$198
Biohaven Pharmaceuticals, Inc.13$196
Vertiflex, Inc.8$185
Daiichi Sankyo Inc.14$175
Collegium Pharmaceutical, Inc.10$153
Scilex Pharmaceuticals Inc.10$150
Si-bone, Inc.6$147
SPR Therapeutics, Inc8$145
Nalu Medical, Inc.1$139
Almatica Pharma LLC5$123
Lundbeck LLC6$118
Teva Pharmaceuticals USA, Inc.7$117
Valinor Pharma, LLC7$109
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC6$98
Averitas Pharma Inc.3$96
Eisai Inc.5$87
Merck4$79
Stimwave Technologies Incorporated3$74
Arbor Pharmaceuticals, Inc.5$69
Assertio Therapeutics, Inc.6$59
Spinal Simplicity, LLC3$54
Vertos Medical, Inc.3$54
Protega Pharmaceutials Inc3$53
Tersera Therapeutics LLC2$51
Shionogi Inc3$50
Stryker2$50
Virtus Pharmaceuticals LLC2$47
Pacira Pharmaceuticals Incorporated1$45
Vertex2$43
Takeda Pharmaceuticals U.S.A., Inc.3$38
Biohaven Pharmaceutical Holding Company Ltd.2$37
International Rehabilitative Sciences, Inc2$29
Medline Industries LP1$26
Alkermes, Inc.1$25
Idorsia Pharmaceuticals US Inc1$24
Azurity Pharmaceuticals, Inc.1$23
Neuronetics, Inc.1$22
Johnson & Johnson1$18
Forte Bio-pharma LLC1$18
Kaleo, Inc.1$18
Xeris Pharmaceuticals, Inc.1$16
ERMI LLC1$13

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$31,510 in reported general payments places this provider in the 90th percentile of 840 pain medicine providers in California.

See all pain medicine providers in California →

Medicare billing

Part B allowed, 2024
$118,954
Medicare patients
266
Services billed
1,533

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen26$851
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen25$501
Gabapentin34$370
Hydromorphone Hcl16$238
Tizanidine Hcl17$231
Baclofen13$160
Pregabalin14$111
Tramadol Hcl13$109
Topiramate15$92

Paid to pharmacies, not to this prescriber.

Other pain medicine in Colton

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →